Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-17
2006-10-17
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S278400
Reexamination Certificate
active
07122562
ABSTRACT:
The invention relates to racemic or enantiomerically pure 4-pyrrolidino derivatives, processes for their preparation, pharmaceutical compositions comprising said derivatives, and their use in the prevention and treatment of illness, in particular which is mediated by monoamine oxidase B inhibitors, in particular Alzheimer's disease or senile dementia.
REFERENCES:
patent: 4287351 (1981-09-01), Bourgery et al.
patent: 0 393 607 (1990-10-01), None
patent: 2500831 (1982-09-01), None
patent: WO 96/40095 (1996-12-01), None
patent: WO 97/33572 (1997-09-01), None
patent: WO 01/34172 (2001-05-01), None
Bach, et al. Proc. Natl. Acad. Sci. USA 85:4934-4938 (1988).
Cesura, et al., A., Prog. Drug Research 38:171-297 (1992).
Fowler, et al. J. Neural. Transm. 49:1-20 (1980).
Benedetti, et al. Biochem. Pharmacol. 38:555-561 (1989).
Saura, et al. Neuroscience 70:755-774 (1996).
Bentué-Ferrer, et al. CNS Drugs 6(3): 217-236 (1996).
Gardner, et al. J. Clin. Psychiatry 57(3):99-104 (1996).
Lam, et al. Tetrahedron Lett. 43:3091-3094 (2002).
Lam, et al. Synlett 5:674-676 (2000).
Chan, et al. Tetrahedron Lett. 39:2933-2936 (1998).
Wolfe, et al. J. Amer. Chem. Soc. 118:7215-7216 (1996).
Schlaeger, E. J., & Christensen, K., Cytotechnology 30:71-83 (1999).
Zhou, et al., Analytical Biochemistry 253:169-174 (1997).
Iding Hans
Jolidon Synese
Krummenacher Daniela
Rodriguez-Sarmiento Rosa Maria
Thomas Andrew William
Hoffmann-La Roche Inc.
Johnston George W.
Morris Patricia L.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
4-pyrrolidino-phenyl-benzyl ether derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-pyrrolidino-phenyl-benzyl ether derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-pyrrolidino-phenyl-benzyl ether derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642286